BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 11353415)

  • 1. Clinical spectrum of chronic acquired demyelinating polyneuropathies.
    Saperstein DS; Katz JS; Amato AA; Barohn RJ
    Muscle Nerve; 2001 Mar; 24(3):311-24. PubMed ID: 11353415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic acquired demyelinating symmetric polyneuropathy classified by pattern of weakness.
    Mygland A; Monstad P
    Arch Neurol; 2003 Feb; 60(2):260-4. PubMed ID: 12580713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bochum ultrasound score allows distinction of chronic inflammatory from multifocal acquired demyelinating polyneuropathies.
    Kerasnoudis A; Pitarokoili K; Gold R; Yoon MS
    J Neurol Sci; 2015 Jan; 348(1-2):211-5. PubMed ID: 25534358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifocal acquired demyelinating sensory and motor neuropathy: report of a case and review of the literature.
    Yang YW; Liu CH; Tsai CH; Lee CC; Jou SB
    Acta Neurol Taiwan; 2004 Mar; 13(1):24-8. PubMed ID: 15315298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asymmetric Acquired Demyelinating Polyneuropathies: MMN and MADSAM.
    Katz JS; Saperstein DS
    Curr Treat Options Neurol; 2001 Mar; 3(2):119-125. PubMed ID: 11180748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic Immune-Mediated Polyneuropathies.
    Cox SZ; Gwathmey KG
    Clin Geriatr Med; 2021 May; 37(2):327-345. PubMed ID: 33858614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and treatment of chronic acquired demyelinating polyneuropathies.
    Latov N
    Nat Rev Neurol; 2014 Aug; 10(8):435-46. PubMed ID: 24980070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recent topics of chronic inflammatory demyelinating polyneuropathy].
    Iijima M
    Rinsho Shinkeigaku; 2012; 52(11):917-9. PubMed ID: 23196467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cranial nerve involvement in typical and atypical chronic inflammatory demyelinating polyneuropathies.
    Shibuya K; Tsuneyama A; Misawa S; Suichi T; Suzuki Y; Kojima Y; Nakamura K; Kano H; Prado M; Kuwabara S
    Eur J Neurol; 2020 Dec; 27(12):2658-2661. PubMed ID: 32876980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distal acquired demyelinating symmetric polyneuropathy progressing to classic chronic inflammatory demyelinating polyneuropathy and response to fludarabine and cyclophosphamide.
    Leitch MM; Sherman WH; Brannagan TH
    Muscle Nerve; 2013 Feb; 47(2):292-6. PubMed ID: 23168526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Demyelinating polyneuropathies in patients with diabetes mellitus and chronic alcoholic intoxication].
    Kovrazhkina EA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(5):41-5. PubMed ID: 22951780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased IP-10 production by blood-nerve barrier in multifocal acquired demyelinating sensory and motor neuropathy and multifocal motor neuropathy.
    Shimizu F; Oishi M; Sawai S; Beppu M; Misawa S; Matsui N; Miyashiro A; Maeda T; Takeshita Y; Nishihara H; Sano Y; Sato R; Kaji R; Kuwabara S; Kanda T
    J Neurol Neurosurg Psychiatry; 2019 Apr; 90(4):444-450. PubMed ID: 30523038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Research criteria for defining patients with CIDP.
    Sander HW; Latov N
    Neurology; 2003 Apr; 60(8 Suppl 3):S8-15. PubMed ID: 12707417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic inflammatory demyelinating polyradiculoneuropathy and variants: where we are and where we should go.
    Nobile-Orazio E
    J Peripher Nerv Syst; 2014 Mar; 19(1):2-13. PubMed ID: 24612201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multifocal motor neuropathy, multifocal acquired demyelinating sensory and motor neuropathy, and other chronic acquired demyelinating polyneuropathy variants.
    Dimachkie MM; Barohn RJ; Katz J
    Neurol Clin; 2013 May; 31(2):533-55. PubMed ID: 23642723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different electrophysiological profiles and treatment response in 'typical' and 'atypical' chronic inflammatory demyelinating polyneuropathy.
    Kuwabara S; Isose S; Mori M; Mitsuma S; Sawai S; Beppu M; Sekiguchi Y; Misawa S
    J Neurol Neurosurg Psychiatry; 2015 Oct; 86(10):1054-9. PubMed ID: 25424435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological characteristics of subtypes of chronic inflammatory demyelinating polyradiculoneuropathy.
    Ikeda S; Koike H; Nishi R; Kawagashira Y; Iijima M; Katsuno M; Sobue G
    J Neurol Neurosurg Psychiatry; 2019 Sep; 90(9):988-996. PubMed ID: 31227562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP): Clinical Features, Diagnosis, and Current Treatment Strategies.
    Reynolds J; Sachs G; Stavros K
    R I Med J (2013); 2016 Dec; 99(12):32-35. PubMed ID: 27902997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of somatosensory evoked potentials in chronic acquired demyelinating neuropathy.
    Yiannikas C; Vucic S
    Muscle Nerve; 2008 Nov; 38(5):1447-1454. PubMed ID: 18932207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic Inflammatory Demyelinating Polyneuropathy.
    Kuwabara S; Misawa S
    Adv Exp Med Biol; 2019; 1190():333-343. PubMed ID: 31760654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.